ISA Pharmaceuticals aims to advance and expand its proprietary pipeline programs independently or in close collaborations with renowned academic institutions and pharmaceutical companies. The Company welcomes investors and strategic partners.
ISA Pharmaceuticals aims to advance and expand its proprietary pipeline programs independently or in close collaborations with renowned academic institutions and pharmaceutical companies. The Company welcomes investors and strategic partners.
Strategic Research Collaborations with the Leiden University Medical Center (LUMC, NL) and Erasmus Medical Center Rotterdam (EMC, NL).